Alphonse Galdes

EVP Pharmaceutical Oper & Tech, Biogen.

Companies

BiogenEVP Pharmaceutical Oper & Tech Sep 26, 2019 to Jan 21, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Biogen BIIB6,034 shares²$1.5M at $241.24Jan 21, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 19, 2022Granted 658 shares of Biogen²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBiogen, EVP Pharmaceutical Oper & Tech
2
SEC EDGARBiogen shares after the filing of Jan 21, 2022